GB0610708D0 - Combination therapy - Google Patents

Combination therapy

Info

Publication number
GB0610708D0
GB0610708D0 GB0610708A GB0610708A GB0610708D0 GB 0610708 D0 GB0610708 D0 GB 0610708D0 GB 0610708 A GB0610708 A GB 0610708A GB 0610708 A GB0610708 A GB 0610708A GB 0610708 D0 GB0610708 D0 GB 0610708D0
Authority
GB
United Kingdom
Prior art keywords
combination therapy
therapy
combination
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB0610708A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AstraZeneca AB
Original Assignee
AstraZeneca AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by AstraZeneca AB filed Critical AstraZeneca AB
Priority to GB0610708A priority Critical patent/GB0610708D0/en
Publication of GB0610708D0 publication Critical patent/GB0610708D0/en
Priority to PL06820574T priority patent/PL1965801T3/en
Priority to US12/158,266 priority patent/US20080306094A1/en
Priority to DK06820574.9T priority patent/DK1965801T3/en
Priority to NZ568812A priority patent/NZ568812A/en
Priority to DE602006020919T priority patent/DE602006020919D1/en
Priority to PCT/GB2006/004768 priority patent/WO2007071970A2/en
Priority to KR1020087016943A priority patent/KR20080077678A/en
Priority to AT06820574T priority patent/ATE502641T1/en
Priority to SI200631009T priority patent/SI1965801T1/en
Priority to JP2008546594A priority patent/JP2009520787A/en
Priority to AU2006328201A priority patent/AU2006328201B2/en
Priority to BRPI0620118-0A priority patent/BRPI0620118A2/en
Priority to CA002631676A priority patent/CA2631676A1/en
Priority to EP06820574A priority patent/EP1965801B1/en
Priority to PT06820574T priority patent/PT1965801E/en
Priority to IL191797A priority patent/IL191797A0/en
Priority to NO20082566A priority patent/NO20082566L/en
Priority to HK09100508.6A priority patent/HK1123976A1/en
Priority to HR20110365T priority patent/HRP20110365T1/en
Priority to CY20111100490T priority patent/CY1111482T1/en
Ceased legal-status Critical Current

Links

GB0610708A 2005-12-22 2006-05-31 Combination therapy Ceased GB0610708D0 (en)

Priority Applications (21)

Application Number Priority Date Filing Date Title
GB0610708A GB0610708D0 (en) 2006-05-31 2006-05-31 Combination therapy
PT06820574T PT1965801E (en) 2005-12-22 2006-12-19 Combination of azd2171 and pemetrexed
JP2008546594A JP2009520787A (en) 2005-12-22 2006-12-19 Combination of AZD2171 and pemetrexed
BRPI0620118-0A BRPI0620118A2 (en) 2005-12-22 2006-12-19 use of azd2171 or a pharmaceutically acceptable salt thereof and permetrexed, pharmaceutical composition, kit, and method for producing an antiangiogenic, and / or vascular permeability reducing effect in a warm-blooded animal
DK06820574.9T DK1965801T3 (en) 2005-12-22 2006-12-19 Combination of azd2171 and pemetrexed
NZ568812A NZ568812A (en) 2005-12-22 2006-12-19 Combination of AZD2171 and pemetrexed
DE602006020919T DE602006020919D1 (en) 2005-12-22 2006-12-19 COMBINATION OF AZD2171 AND PEMETREXED
PCT/GB2006/004768 WO2007071970A2 (en) 2005-12-22 2006-12-19 Combination of azd2171 and pemetrexed
KR1020087016943A KR20080077678A (en) 2005-12-22 2006-12-19 Combination of azd2171 and pemetrexed
AT06820574T ATE502641T1 (en) 2005-12-22 2006-12-19 COMBINATION OF AZD2171 AND PEMETREXED
SI200631009T SI1965801T1 (en) 2005-12-22 2006-12-19 Combination of azd2171 and pemetrexed
PL06820574T PL1965801T3 (en) 2005-12-22 2006-12-19 Combination of azd2171 and pemetrexed
AU2006328201A AU2006328201B2 (en) 2005-12-22 2006-12-19 Combination of AZD2171 and pemetrexed
US12/158,266 US20080306094A1 (en) 2005-12-22 2006-12-19 Combination of Azd2171 and Pemetrexed
CA002631676A CA2631676A1 (en) 2005-12-22 2006-12-19 Combination of azd2171 and pemetrexed
EP06820574A EP1965801B1 (en) 2005-12-22 2006-12-19 Combination of azd2171 and pemetrexed
IL191797A IL191797A0 (en) 2005-12-22 2008-05-28 Combination of azd2171 and pemetrexed
NO20082566A NO20082566L (en) 2005-12-22 2008-06-02 Combination of AZ2171 and permetrexed
HK09100508.6A HK1123976A1 (en) 2005-12-22 2009-01-19 Combination of azd2171 and pemetrexed azd2171
HR20110365T HRP20110365T1 (en) 2005-12-22 2011-05-18 Combination of azd2171 and pemetrexed
CY20111100490T CY1111482T1 (en) 2005-12-22 2011-05-20 COMBINATION AZD2171 AND PERMETRAXED

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0610708A GB0610708D0 (en) 2006-05-31 2006-05-31 Combination therapy

Publications (1)

Publication Number Publication Date
GB0610708D0 true GB0610708D0 (en) 2006-07-12

Family

ID=36694651

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0610708A Ceased GB0610708D0 (en) 2005-12-22 2006-05-31 Combination therapy

Country Status (1)

Country Link
GB (1) GB0610708D0 (en)

Similar Documents

Publication Publication Date Title
IL196559A0 (en) Combination therapy
GB0609492D0 (en) Therapeutic agents
GB0608928D0 (en) Therapeutic agents
GB2436010B (en) Therapy device
IL196556A0 (en) Combination therapy
GB0601962D0 (en) Therapeutic agents
GB0624874D0 (en) Treatment
IL199992A0 (en) Combination therapy
EP2054061A4 (en) Combination therapy
GB0616214D0 (en) Therapeutic Agents
GB0611152D0 (en) Therapeutic agents
GB0504206D0 (en) Combination therapy
GB0719518D0 (en) Therapy
GB0620818D0 (en) Therapeutic agents
IL198026A0 (en) Sequential combination therapy
GB0620059D0 (en) Therapeutic agents
ZA200902203B (en) Combination therapy
GB0609676D0 (en) Therapeutic agents
EP2211863A4 (en) Combination therapy
GB0700284D0 (en) Combination therapy
GB0604460D0 (en) Treatment
GB0622195D0 (en) Therapeutic agents
GB0606660D0 (en) Targeted Therapy
GB0716072D0 (en) Therapy
GB0700635D0 (en) Therapy

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)